Samantha Marrone, MD
Procedural Dermatology · Orlando, FLNPI 1780030130
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.5% of the total across 815 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 34 manufacturers reported payments, led by AbbVie at 25.1% of the total. 2025 is the largest year on record at $4,997, 2.4 times the $2,083 reported in 2019. Among procedural dermatology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 815 payments — averaging $27.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- Johnson & Johnson$1K
- E.r. Squibb & Sons, L.L.C.$1K
- Pfizer$1K
- Amgen$1K
- Janssen Scientific Affairs, LLC$1K
- plus $10K from 28 others
What the payments were for
- Speaking & faculty fees$1181%
- Food & beverage$21,22495%
- Education$8924%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 171 | $5,585 |
| Johnson & Johnson | 113 | $1,450 |
| E.r. Squibb & Sons, L.L.C. | 38 | $1,413 |
| Pfizer | 45 | $1,326 |
| Amgen | 43 | $1,325 |
| Janssen Scientific Affairs, LLC | 12 | $1,283 |
| Galderma Laboratories, L.p. | 54 | $1,214 |
| Regeneron Healthcare Solutions, Inc. | 28 | $892 |
| Sun Pharmaceutical Industries Inc. | 32 | $847 |
| Lilly USA, LLC | 25 | $792 |
| Arcutis Biotherapeutics, Inc. | 37 | $774 |
| Sanofi | 30 | $762 |
| Incyte Corporation | 30 | $746 |
| UCB, Inc. | 16 | $567 |
| LEO Pharma Inc. | 25 | $546 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 20 | $417 |
| Journey Medical Corporation | 7 | $379 |
| Dermavant Sciences, Inc. | 18 | $341 |
| Almirall LLC | 16 | $295 |
| EPI Health, LLC | 8 | $182 |
| Novartis | 8 | $175 |
| Botanix SB Inc | 11 | $149 |
| Mayne Pharma Commercial LLC | 7 | $142 |
| Stemline Therapeutics Inc. | 1 | $122 |
| Bristol Myers Squibb | 1 | $83 |
| Sanofi-aventis U.S. LLC | 1 | $80 |
| Merck | 1 | $67 |
| Fresenius Kabi USA, LLC | 3 | $65 |
| Verrica Pharmaceuticals Inc. | 3 | $58 |
| Sebela Pharmaceuticals Inc. | 4 | $54 |
| Organon | 3 | $38 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $28 |
| Biofrontera Inc. | 1 | $21 |
| VYNE Pharmaceuticals Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$22,234 in reported general payments places this provider in the 90th percentile of 60 procedural dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 11 | $230,854 |
| Dupixent PenDupilumab | 52 | $201,356 |
| Taltz AutoinjectorIxekizumab | 11 | $74,852 |
| Clobetasol Propionate | 163 | $5,246 |
| Fluorouracil | 42 | $2,726 |
| Tretinoin | 29 | $2,496 |
| Ketoconazole | 135 | $2,345 |
| Triamcinolone Acetonide | 136 | $2,057 |
| Fluticasone Propionate | 85 | $2,027 |
| Clindamycin Phosphate | 60 | $1,873 |
| CiclopiroxCiclopirox Olamine | 73 | $1,377 |
| Mometasone Furoate | 39 | $760 |
| Doxycycline Hyclate | 92 | $714 |
| Betamethasone Dipropionate | 13 | $670 |
| Hydroxyzine Hcl | 94 | $627 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Orlando
- Ronald KnipeOrlando$6K
- James KnightOrlando$835
- Luis SoroFort Lauderdale$307K
- Laertes ManuelidisFort Myers$252K
- Michael ScannonTampa$218K
- Christopher OconnellCoral Gables$76K
- Dimitry PalceskiWinter Park$23K
- Robert BrownOrange Park$22K
- Ileana Perez-QuintairosSouth Miami$16K
- Lawrence StrongWellington$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.